Printer Friendly

Browse Clinical trials topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Aurion Biotech trial shows IOTA cell therapy can restore vision to patients with blindness resulting from corneal endothelial disease. Jul 26, 2021 286
AbbVie's DALVANCE receives US FDA approval. Jul 26, 2021 160
AbbVie's DALVANCE receives US FDA approval. Jul 26, 2021 161
Acticor Biotech Completes Enrollment in its GARDEN Clinical Trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study. Clinical report Jul 23, 2021 449
Abeona activates second clinical trial site for EB-101 Phase 3 VITAL study. Jul 23, 2021 188
Landos Biopharma to present Phase 3 data of omilancor in UC at UEGW. Jul 22, 2021 280
Biogen says FDA approval of ADUHELM based on thorough analysis of data. Jul 22, 2021 705
Adagene announces clinical trial collaboration with Merck. Jul 22, 2021 258
eFFECTOR Therapeutics doses first patient in Phase 1b trial of zotatifin. Jul 22, 2021 304
Antares Pharma announces FDA acceptance of IND application for ATRS-1902. Jul 22, 2021 262
RenovaCare provides update on clinical trial for SkinGun, CellMist System. Jul 22, 2021 178
Eureka Therapeutics Initiates Phase I/II ARYA-3 Clinical Trial of GPC3 Targeting ARTEMIS T Cell Therapy in Liver Cancer. Jul 22, 2021 422
Antengene's ATG-101 clinical trial application receives Australian regulatory approval. Jul 22, 2021 157
Antengene's ATG-101 clinical trial application receives Australian regulatory approval. Jul 22, 2021 156
Free Event Explores Real Clinical Trial Experiences. CISCRP Jul 22, 2021 230
First Patient Enrolled in Clinical Trial for Vicineum in China. Jul 21, 2021 746
Merck Presents New Data from Ongoing Phase 2a Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of Investigational, Once-Monthly, Oral Islatravir for HIV-1 Prevention. Jul 21, 2021 664
Direct awarded US FDA approval to commence a Phase I/II trial of ExoFlo for post-acute COVID-19 syndrome. Jul 21, 2021 261
Direct awarded US FDA approval to commence a Phase I/II trial of ExoFlo for post-acute COVID-19 syndrome. Jul 21, 2021 260
Boston Scientific reports 'positive' results from PINNACLE FLX clinical trial. Clinical report Jul 21, 2021 278
Oramed's Oravax oral vaccine clinical trial approved by Israel's IRB. Jul 21, 2021 244
Sorrento Therapeutics doses COVID-19 patients in Phase 2 trial for COVIDROPS. Jul 21, 2021 310
Acadia Pharmaceuticals phase 3 trial of pimavanserin met primary endpoint. Clinical report Jul 21, 2021 218
Taiwan CECC mulls trials on mixing domestic COVID vaccine with others. Jul 21, 2021 195
MediWound says primary endpoints met in Phase 3 pediatric study of NexoBrid. Clinical report Jul 20, 2021 788
Rain Therapeutics initiates Phase 3 MANTRA clinical trial of milademetan. Jul 20, 2021 252
Wave Life Sciences initiates dosing in Phase 1b/2a FOCUS-C9 trial of WVE-004. Jul 20, 2021 285
Sesen Bio, Qilu announce enrollment of first patient in Vicineum trial in China. Jul 20, 2021 170
1,000 second doses of Nano Covax COVID-19 vaccine administered to volunteers in third-phase trials. Jul 20, 2021 275
BlueRock Therapeutics DA01 receives Fast Track designation for advanced Parkinson's disease. Jul 20, 2021 177
BlueRock Therapeutics DA01 receives Fast Track designation for advanced Parkinson's disease. Jul 20, 2021 176
Merck says islatravir 'well tolerated versus placebo' in Phase 2a trial. Jul 20, 2021 155
Kadmon says ROCKstar clinical trial of REZUROCK to treat cGVHD published. Jul 19, 2021 154
Prometheus announces initiation of phase 2 clinical trial of PRA023. Clinical report Jul 19, 2021 163
Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain. Jul 19, 2021 482
NAFDAC Insists On Clinical Trial For COVID-19 Herbal Medicine. Jul 18, 2021 893
Synlogic commences phase one SYNB1934 clinical trial to treat Phenylketonuria. Jul 16, 2021 231
Synlogic commences phase one SYNB1934 clinical trial to treat Phenylketonuria. Jul 16, 2021 230
Zendal, IAVI Partner to Advance the Tuberculosis Vaccine Candidate MTBVAC into Efficacy Trials. Jul 16, 2021 675
Castor Raises USD 45m Series B to Modernize the Clinical Trial Process. Jul 16, 2021 406
AstraZeneca-jabbed up to 3 times more likely to get Covid than Pfizer, study claims; Scientists at Imperial College London have used estimates from clinical trial data, including Public Health England, to suggest the AstraZeneca jab preventing symptoms of Covid less than Pfizer. By, Ryan Merrifield Jul 16, 2021 591
Medable sets up new EMEA HQ in Dublin to support clinical trial deployments in Europe. Jul 15, 2021 223
Medable sets up new EMEA HQ in Dublin to support clinical trial deployments in Europe. Jul 15, 2021 222
Medable sets up new EMEA HQ in Dublin to support clinical trial deployments in Europe. Jul 15, 2021 225
Transcenta Holding doses first US patient in global TST005 phase one clinical trial. Jul 15, 2021 166
Transcenta Holding doses first US patient in global TST005 phase one clinical trial. Jul 15, 2021 167
13,000 shots of Nano Covax vaccine administered to volunteers in third trial phase. Jul 15, 2021 237
Theratechnologies initiates search for partner for Phase 3 tesamorelin trial. Jul 15, 2021 341
FDA accepts NLS Pharmaceutics' Quilience IND application to treat narcolepsy. Jul 15, 2021 193
Vir Biotechnology initiates Phase 2 clinical trial evaluating VIR-2218, VIR-3434. Jul 15, 2021 178
Eli Lilly, Banner Alzheimer's Institue collaborate on Phase 3 trial of donanemab. Clinical report Jul 15, 2021 190
Merck reports 'positive' event-free survival data from Phase 3 KEYNOTE-522 study. Jul 15, 2021 337
ImmunityBio Authorized to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-Cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against COVID-19. Jul 15, 2021 759
AVM Biotechnology receives FDA approval to alter ongoing clinical study. Jul 14, 2021 194
Kintor Pharmaceutical's GT20029 Investigational New Drug application receives US FDA approval. Jul 14, 2021 164
Micron begins first microneedle vaccine clinical trial for measles and rubella at the London School of Hygiene and Tropical Medicine in The Gambia. Jul 14, 2021 265
Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. Jul 14, 2021 156
AVM Biotechnology receives FDA approval to alter ongoing clinical study. Jul 14, 2021 195
Kintor Pharmaceutical's GT20029 Investigational New Drug application receives US FDA approval. Jul 14, 2021 165
First Patient Dosed in Phase 1 Clinical Trial Evaluating CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma. Jul 14, 2021 607
FDA Approves Accelerated Dosing in Non-Hodgkin's Lymphoma/Leukemia Clinical Trial. Jul 14, 2021 417
Micron begins first microneedle vaccine clinical trial for measles and rubella at the London School of Hygiene and Tropical Medicine in The Gambia. Jul 14, 2021 264
Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. Jul 14, 2021 155
Tevogen Bio wins FDA clearance of IND Application for TVGN-489 for COVID-19. Jul 13, 2021 232
Tevogen Bio wins FDA clearance of IND Application for TVGN-489 for COVID-19. Jul 13, 2021 231
Merck Presents Interim Results from Phase 2/3 Studies of Molnupiravir, an Investigational Oral Antiviral Therapeutic for Mild to Moderate COVID-19. Jul 13, 2021 351
Lava Therapeutics announces treatment of first patient in Phase 1/2a of LAVA-051. Jul 13, 2021 306
Genocea doses first patient in Phase 1/2a TiTAN clinical trial for GEN-011. Jul 13, 2021 166
Galecto resumes recruitment in Phase 2b global GALACTIC-1 trial of GB0139. Jul 13, 2021 184
TFF Pharmaceuticals announces preliminary data from Phase 1 clinical trial. Jul 13, 2021 291
Hepion announces all primary endpoints achieved in Phase 2a AMBITION trial. Jul 13, 2021 313
ARCA Biopharma provides update on ASPEN-COVID-19 Phase 2b clinical trial. Jul 13, 2021 269
Moleculin Biotech receives approval for amendment in Annamycin trial. Jul 13, 2021 176
Aptorum Group Touts Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus aureus. Jul 13, 2021 359
Solidarity trial also seeks to identify Covid-19 vaccine suited for Filipinos. Jul 13, 2021 255
Pakistan earned $10mn from CanSino phase 3 trials: NIH. Jul 12, 2021 284
Kintor receives USFDA approval for pyrilutamide phase two clinical trial. Jul 12, 2021 227
ReiThera announces safe preliminary Phase 2 data from its GRAd-COV2 vaccine candidate. Jul 12, 2021 252
Kintor receives USFDA approval for pyrilutamide phase two clinical trial. Jul 12, 2021 226
Lysogene Receives FDA Fast Track Designation for LYS-GM101 Gene Therapy for the Treatment of GM1 Gangliosidosis. Jul 12, 2021 415
ReiThera announces safe preliminary Phase 2 data from its GRAd-COV2 vaccine candidate. Jul 12, 2021 251
Inotrem Receives Approval to Expand Nangibotide Clinical Trial in Critically Ill COVID-19 Patients and Receives Additional Public Funding of EUR 45m. Jul 12, 2021 801
Merck, Ridgeback report interim data from Phase 2/3 studies of molnupiravir. Jul 12, 2021 215
Arcutis announces first patient enrolled in phase 3 trial of ARQ-154. Jul 12, 2021 175
Summit Therapeutics presents data from Phase II studies on ridinilazole. Jul 12, 2021 264
Equillium to begin Phase 3 of itolizumab to treat severe autoimmune diseases. Jul 12, 2021 315
Prilenia's Phase 3 Huntington's Disease Clinical Trial Achieves 50% Enrollment. Jul 12, 2021 291
FDA Approves of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme. Jul 12, 2021 393
Morphic reports data from Phase 1 study of MORF-057. Jul 9, 2021 508
AIM ImmunoTech announces Phase 2a Human Challegene Trial of Ampligen. Jul 9, 2021 270
Galectin Therapeutics announces results from Phase 1b trial extension. Jul 9, 2021 374
Akston Biosciences Touts Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate. Jul 9, 2021 421
Celldex presents 'positive' data from CDX-0159 phase 1b study. Jul 9, 2021 274
SZAMBU completes volunteer recruitment for Covid-19 vaccine trial. Jul 8, 2021 424
Can-Fite done preparing for start of patient enrollment in Namodenoson study. Jul 8, 2021 202
Lysogene reports FDA fast track designation for LYS-GM101 gene therapy. Jul 8, 2021 201
PureTech Inks Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors. Jul 8, 2021 641
We need Shs2b for Covidex clinical trials, says Ogwang. Jul 8, 2021 1824
Sanofi and GSK get approval for late-stage trial of COVID-19 vaccine candidate in India. Jul 8, 2021 194
Sanofi and GSK get approval for late-stage trial of COVID-19 vaccine candidate in India. Jul 8, 2021 195
Alvotech Initiates Clinical Studies for AVT04, A Proposed Biosimilar to Stelara (Ustekinumab). Jul 8, 2021 948
Oxford scientists begin trial on novel HIV vaccine. Jul 7, 2021 238
Trials for cattle TB vaccine begin; NEWS IN BRIEF. Jul 7, 2021 162
Oxford scientists begin trial on novel HIV vaccine. Jul 7, 2021 238
Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. Jul 7, 2021 258
Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. Jul 7, 2021 257
Iveric Bio Receives FDA Agreement Under Special Protocol Assessment for GATHER2 Phase 3 Clinical Trial of Zimura in Geographic Atrophy Secondary to Age-Related Macular Degeneration. Jul 7, 2021 783
PureTech in clinical trial supply pact with BeiGene to evaluate tislelizumab. Jul 7, 2021 299
Abeona Therapeutics updates EB-101 Phase 1/2a results in RDEB. Jul 7, 2021 197
Atossa receives regulatory approval to open study of AT-H201 in Australia. Jul 7, 2021 277
Fresh hope to end badger cull as bTB skin test trials for cows get underway; The move, coupled with the pilot of a vaccine, could spell the end for the badger killing programme within four years. By, Ben Glaze Jul 7, 2021 767
Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. Jul 6, 2021 270
China Regulator Accepts Antengene IND Application for the Phase II Clinical Trial of Single-Agent Selinexor for the Treatment of Myelofibrosis. Jul 6, 2021 762
Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. Jul 6, 2021 271
Iveric bio receives FDA agreement under SPA for GATHER2 Phase 3 trial. Jul 6, 2021 424
CytoSorbents receives full FDA approval of IDE for U.S. STAR-T trial. Jul 6, 2021 251
Arrowhead announces interim clinical data from AROHIF21001 cohorts. Clinical report Jul 6, 2021 354
Adial Pharmaceuticals says Phase 3 ONWARD trial nears enrollment completion. Jul 6, 2021 264
FDA clears Sorrento Phase 2 trial of resiniferatoxin for OA knee pain. Jul 6, 2021 199
Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara. Jul 6, 2021 337
Phase 2 Glioblastoma Trial Shows Improved Progression-Free Survival. Jul 5, 2021 343
Two FDA-Sanctioned Clinical Trials In Parkinson's. Jul 5, 2021 210
Globe Biotech workers assaulted while catching monkeys for vaccine trial. Jul 4, 2021 296
Final stage of human trials for homegrown Nano Covax vaccine begins. Jul 2, 2021 235
Eric 'rings the bell' after poster helped him see off cancer; ex-builder opted for trial treatment. ELLEN KIRWIN ECHO Reporter ellen.kirwin@trinitymirror.com @ellen_kirwin Jul 2, 2021 495
DOST waiting for WHO protocol on vaccine trials. Jul 1, 2021 424
HDT Bio Receives Notice to Proceed from FDA for US Phase 1 Clinical Trial of RNA COVID-19 Vaccine. Jul 1, 2021 430
Ault Global Holdings portfolio company Alzamend submits AL001 IND in Alzheimer's. Jul 1, 2021 278
Kintara Therapeutics announces topline Phase 2 data results of VAL-083 in GBM. Financial report Jul 1, 2021 178
Achilles Therapeutics enroll first patient in ongoing Phase I/IIa study in NSCLC. Jul 1, 2021 279
Alzamend Neuro Submits IND Application for AL001 for Dementia Related to Alzheimer's Disease. Jul 1, 2021 515
Precision BioSciences Doses First Patient in Phase 1 Allogeneic CAR T Clinical Trial of PBCAR19B Immune Evading Stealth Cell for Relapsed/Refractory Non-Hodgkin Lymphoma. Jul 1, 2021 542
AM-Pharma Enrolls First Patient in Japan for Ongoing Phase III SA-AKI Pivotal REVIVAL Trial. Jul 1, 2021 460
Novavax publishes results of UK Phase 3 trial of Covid-19 vaccine in NEJM. Jun 30, 2021 210
Ocuphire Pharma says VEGA-1 Phase 2 trial meets primary, secondary endpoints. Jun 30, 2021 246
Allogene Therapeutics granted Fast Track designation for ALLO-605. Jun 30, 2021 221
Sellas Life Sciences reports data from ongoing Phase 1/2 study of GPS. Jun 30, 2021 568
Savara announces first patient dosed in Phase 3 aPAP trial. Jun 30, 2021 189
Cuba commences vaccine trials on children with its domestic COVID-19 vaccine. Jun 30, 2021 198
Cuba commences vaccine trials on children with its domestic COVID-19 vaccine. Jun 30, 2021 197
Direct Biologics wins FDA approval for Phase I/II trial for ExoFlo to treat mild-to-moderate COVID-19. Jun 30, 2021 201
Direct Biologics receives US FDA approval for ExoFlo Phase I/II trial. Jun 30, 2021 178
Direct Biologics wins FDA approval for Phase I/II trial for ExoFlo to treat mild-to-moderate COVID-19. Jun 30, 2021 202
Direct Biologics receives US FDA approval for ExoFlo Phase I/II trial. Jun 30, 2021 179
First Patient Dosed in Phase 1 Study of VNRX-9945 for the Treatment of Chronic Hepatitis B Virus Infection. Jun 30, 2021 348
First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis Trial. Jun 30, 2021 393
Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-ANG3 for Treatment of Mixed Dyslipidemia. Jun 30, 2021 365
Lassa fever vaccine undergoing clinical trial in Nigeria - US. Jun 29, 2021 607
Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. Jun 29, 2021 202
Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. Jun 29, 2021 201
Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. Jun 29, 2021 203
VBI Vaccines Touts Initial Positive Phase 1 Data for Its eVLP Vaccine Candidate Against COVID-19. Jun 29, 2021 400
SAB Biotherapeutics Doses First Participant in Phase 2a Trial of SAB-176 for the Treatment of Influenza. Jun 29, 2021 531
Cerevel Therapeutics announces results from Phase 1b clinical trial of CVL-231. Financial report Jun 29, 2021 179
Altimmune announces update on AdCOVID Phase 1 Clinical trial. Jun 29, 2021 181
Altimmune to terminate further enrollment, evaluate future options for T-COVID. Jun 29, 2021 219
Kymera Therapeutics reports 'positive' results from Phase 1 trial of KT-474. Jun 28, 2021 302
AstraZeneca says first participants vaccinated in COVID-19 variant vaccine trial. Jun 28, 2021 195
Anavex announces results of ANAVEX 2-73 in phase 2 clinical trial. Financial report Jun 28, 2021 459
Galera Therapeutics completes enrollment of phase 3 trial of avasopasem. Jun 28, 2021 183
WPD Pharmaceuticals plans to commence Phase 1b/II study of berubicin. Jun 28, 2021 608
Crinetics announces dosing of first patient in phase 3 PATHFNDR-1 study. Jun 28, 2021 171
Onconova provides update on Phase 1/2a trial of rigosertib-nivolumab combination. Jun 28, 2021 160
Dare Bioscience announces Phase 1 results for DARE-HRT1. Financial report Jun 28, 2021 730
Catalyst Biosciences receives FDA Fast Track Designation for subcutaneous MarzAA. Jun 28, 2021 206
Oric Pharmaceuticals announces FDA clearance of IND application for ORIC-533. Jun 28, 2021 256
Veru announce presentation of Phase 1b/2 clinical study update for sabizabulin. Jun 28, 2021 153
Ampio Pharmaceuticals initiates patient randomization and dosing in AP-019 Phase II study of inhaled Ampion in COVID-19 respiratory distress. Jun 28, 2021 211
Ampio Pharmaceuticals initiates patient randomization and dosing in AP-019 Phase II study of inhaled Ampion in COVID-19 respiratory distress. Jun 28, 2021 212
AstraZeneca commences trial testing of COVID-19 vaccine against the Beta virus variant. Jun 28, 2021 187
American Diabetes Association's clinical trial finds dapagliflozin was well tolerated in hospitalised COVID-19 patients. Jun 28, 2021 254
AstraZeneca commences trial testing of COVID-19 vaccine against the Beta virus variant. Jun 28, 2021 186
American Diabetes Association's clinical trial finds dapagliflozin was well tolerated in hospitalised COVID-19 patients. Jun 28, 2021 253
Patient Randomization and Dosing Starts in Ampio Pharmaceuticals AP-019 Phase II Study of Inhaled Ampion in COVID-19 Respiratory Distress. Jun 28, 2021 285
Taiwan's UBI claims vaccine effective against Delta variant, booster trials soon in US. Jun 28, 2021 303
First trials for cancer vaccine under way in the city. JONATHAN HUMPHRIES ECHO reporter jonathan.humphries@trinitymirror.com @JHUMPHRIESECHO Jun 28, 2021 488
Intellia, Regeneron announce interim data from Phase 1 study of NTLA-2001. Jun 27, 2021 440
Health ministry aims to complete third phase human trial of Vietnamese-made vaccine in August. Jun 26, 2021 471
S. Korea to give all-out support for phase 3 trials of homegrown COVID-19 vaccine candidates. Jun 25, 2021 298
Sirnaomics doses first patient with STP705 in Phase one United States clinical study for liver cancer. Clinical report Jun 25, 2021 158
Sirnaomics doses first patient with STP705 in Phase one United States clinical study for liver cancer. Clinical report Jun 25, 2021 159
Phase III Pivotal Trial of Once Weekly Exenatide in Adolescents aged 10-17 Shows Benefit for the Treatment of Type 2 Diabetes. Jun 25, 2021 262
Evaluation of the distance between the central teeth after frenectomy: a randomized clinical study. Tanik, Abdulsamet; Cicek, Yasin Clinical report Jun 25, 2021 4255
Veru enrolls first patient in phase 3 VERACITY clinical trial of sabizabulin. Clinical report Jun 25, 2021 263
Vir Biotechnology presents clinical data from trials of VIR-2218, VIR-3434. Jun 25, 2021 732
AstraZeneca reports exenatide Phase 3 trial in adolescents met primary endpoint. Jun 25, 2021 170
Applied Genetic reports 12-month data from ongoing Phase 1/2 trial of ACHM B3. Jun 24, 2021 293
Applied Genetic reports 12-month data from ongoing Phase 1/2 trial of ACHM A3. Jun 24, 2021 151
Longeveron announces abstract on data of Phase 1 trial of Lomecel-B infusion. Jun 24, 2021 210
Brickell Biotech announce initiation of Phase 1 study of sofpironium bromide gel. Jun 24, 2021 209
BioVie announces first patient enrolled in BIV201 Phase 2b clinical trial. Jun 24, 2021 233
Aeglea BioTherapeutics begins dosing in Phase 1/2 trial of AGLE-177. Jun 24, 2021 171
Kura Oncology doses first patient in Phase 1b portion of KOMET-001 trial. Jun 24, 2021 191
US FDA approves Resolve Therapeutics' phase two clinical trial of RSLV-132 in long COVID patients. Jun 24, 2021 212
NIH commences clinical trial to evaluate immune response of COVID-19 vaccines in pregnant women. Jun 24, 2021 177
US FDA approves Resolve Therapeutics' phase two clinical trial of RSLV-132 in long COVID patients. Jun 24, 2021 211
Resolve Therapeutics announces FDA approval to commence phase 2 trial of RSLV-132 in long COVID patients. Jun 24, 2021 231
Resolve Therapeutics announces FDA approval to commence phase 2 trial of RSLV-132 in long COVID patients. Jun 24, 2021 232
First Patient Dosed in Synergy, ALPN-101 Phase 2 Lupus Clinical Trial and USD 45m in Development Milestones Achieved Under AbbVie Collaboration. Jun 24, 2021 333
Shenzhen Kangtai Biological Products Co Ltd announces launch of Phase III clinical trial of BIOKANGTAI COVID-19 vaccine in Malaysia. Jun 23, 2021 191
Innovent Biologics meets overall survival primary endpoint in phase 3 ORIENT-15 study. Clinical report Jun 23, 2021 193
Shenzhen Kangtai Biological Products Co Ltd announces launch of Phase III clinical trial of BIOKANGTAI COVID-19 vaccine in Malaysia. Jun 23, 2021 190
Innovent Biologics meets overall survival primary endpoint in phase 3 ORIENT-15 study. Clinical report Jun 23, 2021 192
Seven and Eight Biopharmaceuticals Inc. Announces the First Patient Treated in a First-in-Human Clinical Trial of the TLR7/8 Dual Agonist BDB018 in Advanced Solid Tumors. Jun 23, 2021 271
Poxel and Sumitomo Dainippon Pharma Announce the Approval of TWYMEEG for the Treatment of Type 2 Diabetes in Japan. Jun 23, 2021 461
AstraZeneca's Orpathys granted conditional approval in China to treat NSCLC. Jun 23, 2021 154
BioCardia says DSMB recommends continuation of Phase III CardiAMP study. Jun 23, 2021 196
XBiotech announces first patient enrolled in clinical trial evaluating XB2001. Clinical report Jun 23, 2021 205
Entera Bio announce phase 2 BMD data for EB613. Clinical report Jun 23, 2021 548
Medicenna submits clinical trial application in Australia for study of MDNA11. Report Jun 23, 2021 317
Alterity Therapeutics receives EU guidance for Phase 2 trial of MSA candidate. Jun 23, 2021 153
E.U. grants AstraZeneca/Merck's Koselugo conditional approval for PN treatment. Jun 22, 2021 221
Dicerna begins dosing on ESTRELLA trial of belcesiran for AATLD treatment. Jun 22, 2021 182
BioCardia to present CardiAMP cell therapy trial data. Jun 22, 2021 232
Jupiter Wellness publishes results of clinical study for eczema treatment. Clinical report Jun 22, 2021 276
Antares Pharma announces submission of IND application for ATRS-1902. Jun 22, 2021 233
Sorrento Therapeutics Phase 2 abivertinib studies have completed enrollment. Clinical report Jun 22, 2021 180
ADC Therapeutics announces interim results from Phase 2 clinical trial of Cami. Jun 22, 2021 325
Hope Biosciences Stem Cell Research Foundation wins FDA's approval for simultaneous stem cell trials for Parkinson's Disease. Jun 22, 2021 205
Hope Biosciences Stem Cell Research Foundation wins FDA's approval for simultaneous stem cell trials for Parkinson's Disease. Jun 22, 2021 204
Xentria Initiates Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis. Jun 22, 2021 383
MediciNova announces publication of results from Phase 2 trial of MN-166. Clinical report Jun 21, 2021 281
Sierra Oncology announces completion of enrollment for MOMENTUM phase 3 trial. Jun 21, 2021 185
Anavex announces data from Phase 2 trial of ANAVEX 2-73. Jun 21, 2021 414
Aligos Therapeutics to present Phase 1 data for ALG-010133. Drug overview Jun 21, 2021 876
Immutep to evaluate efti in triple combination therapy Phase I study. Jun 21, 2021 201
Syneos Health accelerates decentralized clinical trial delivery. Jun 21, 2021 230
Moleculin Biotech enrolls, doses first patient in phase 1b/2 trial of annamycin. Jun 21, 2021 237
Cassava Sciences to initiate Phase 3 program of simufilam in 2H21. Jun 21, 2021 199
AIM ImmunoTech completes all treatments in Phase 1 study of ampligen. Jun 21, 2021 262
Cassava selects Premier Research for Phase 3 of Alzheimer's program. Jun 21, 2021 162
Vicky: I'm not looking for a miracle ...all I want is more time; CERVICALCHECK SURVIVOR VICKY Y PREPARES TO FLY HOME TO FAMILY Battler Vicky coping through trial cancer treatment EXCLUSIVE. SYLVIA POWNALL Jun 20, 2021 1270
WHO to cover 3 vaccines in Philippines trials. Jun 20, 2021 426
Vicky taken to hospital after clinical trial scare. MARITA MOLONEY Jun 19, 2021 216
Appili Therapeutics Inc expands COVID-19 PRESECO Clinical Trial of Avigan/Reeqonus into Mexico and Brazil. Jun 18, 2021 237
Jacobio Pharmaceuticals doses first patients in clinical trial of SHP2 inhibitor JAB-3312 in combination with Pembrolizumab and Binimetinib. Jun 18, 2021 162
Bangladeshi COVID-19 vaccine gets conditional clearance for human trials. SHEHAB SUMON Jun 18, 2021 519
Appili Therapeutics Inc expands COVID-19 PRESECO Clinical Trial of Avigan/Reeqonus into Mexico and Brazil. Jun 18, 2021 236
Jacobio Pharmaceuticals doses first patients in clinical trial of SHP2 inhibitor JAB-3312 in combination with Pembrolizumab and Binimetinib. Jun 18, 2021 161
Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan. Clinical report Jun 18, 2021 539
Iveric bio to present GATHER2 enrollment data, GATHER1 analyses. Jun 18, 2021 236
ADC Therapeutics presents data on four Zynlonta clinical trials. Jun 18, 2021 301
Novartis reports data from completed two-copy cohort of Phase 3 SPR1NT trial. Jun 18, 2021 242
Aerie Pharma completes enrollment in Phase 3 trial of ophtalmic solution. Jun 17, 2021 176
Viking Therapeutics reports results from Phase 1 trial of VK0214. Jun 17, 2021 208
Biogen announces first patient dosed in phase 3 clinical study of TOPAZ-1. Clinical report Jun 17, 2021 262
Appili Therapeutics Expands PRESECO Clinical Trial of Avigan/Reeqonus for Mild-to-Moderate COVID-19 Patients into Mexico and Brazil. Jun 17, 2021 773
Over-70s wanted for booster vaccine trial. Jun 17, 2021 222
Geron says IMbark Phase 2 data published in Journal of Clinical Oncology. Clinical report Jun 17, 2021 231
SpringsWorks Therapeutics initiates Phase 1/2 trial of mirdametinib in glioma. Jun 16, 2021 191
RECOVERY trial finds Regeneron's COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies. Jun 16, 2021 246
Organicell Touts Positive Results of Their Expanded Access Trial for the Treatment of Mild to Moderate COVID-19 Using Zofin. Jun 16, 2021 364
China's nasal-spray Covid-19 vaccines undergoing clinical trials:. Xinhua News Agency Jun 16, 2021 315
Ashvattha Therapeutics Touts Positive Interim Data from Ongoing Phase 2 PRANA Clinical Study of OP-101 in Severe COVID-19 Patients. Clinical report Jun 16, 2021 159
RECOVERY trial finds Regeneron's COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies. Jun 16, 2021 247
Freeline doses second patient in Phase 1/2 MARVEL-1 clinical trial. Jun 16, 2021 172
Altimmune announces interim data from ALT-801 phase 1 trial. Jun 16, 2021 319
uniQure enrolls first two patients in second cohort phase I/II trial of AMT-130. Clinical report Jun 16, 2021 195
Aprea Therapeutics announces Phase 1/2 clinical trial results. Jun 16, 2021 259
Argenx announces publication of Phase 3 ADAPT results in The Lancet Neurology. Financial report Jun 16, 2021 317
Innovent Biologics doses first subject IBI362 phase two clinical trial. Clinical report Jun 15, 2021 295
Ascentage Pharma's lisaftoclax Investigational New Drug application receives US FDA approval. Jun 15, 2021 167
Innovent Biologics doses first subject IBI362 phase two clinical trial. Clinical report Jun 15, 2021 296
Ascentage Pharma's lisaftoclax Investigational New Drug application receives US FDA approval. Jun 15, 2021 168
Taiwanese COVID vaccine developer to conduct clinical trials in Paraguay. Jun 15, 2021 267
Clearside report 'positive' safety results from OASIS Phase 1/2a trial of CLS-AX. Jun 15, 2021 255
Otonomy initiates expansion of Phase 1/2 clinical trial for OTO-413. Clinical report Jun 15, 2021 168
Salarius Pharmaceuticals announces new clinical trial to study seclidemstat. Jun 15, 2021 189
Eyenovia provides update on three Phase 3 programs. Jun 15, 2021 322
LivaNova gets FDA approval for study to evaluate aura6000 to treat Sleep Apnea. Jun 15, 2021 247
First batch of Kangtai developed Covid-19 vaccine arrives in Malaysia for clinical trial. Jun 14, 2021 595
Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in US NDA Phase 3 Clinical Trials for iDose TR. Jun 14, 2021 417
Chula launches human trials of Thai Covid vaccine. Jun 14, 2021 263
Novavax's COVID-19 vaccine found to be more than 90% effective in US clinical trial. Jun 14, 2021 293
ImmVira announces completion of first dosing in phase II clinical trials of MVR-T3011 in US and China. Jun 14, 2021 197
Novavax's COVID-19 vaccine found to be more than 90% effective in US clinical trial. Jun 14, 2021 294
ImmVira announces completion of first dosing in phase II clinical trials of MVR-T3011 in US and China. Jun 14, 2021 198
Novavax COVID-19 vaccine shows 90% efficacy, 100% protection in PREVENT-19 trial. Jun 14, 2021 466
Landos Biopharma announce outcome of End-of-Phase 2 meeting with FDA. Jun 14, 2021 212
Terns Pharmaceuticals reports results from phase 2a LIFT study of TERN-101. Clinical report Jun 14, 2021 299
Rapt Therapeutics reports 'positive' results from Phase 1b RPT193 trial. Financial report Jun 14, 2021 257
C4 Therapeutics first patient dosed in phase 1/2 clinical trial on CFT7455. Jun 14, 2021 238
Fusion Pharmaceuticals reports results from Phase 1 study of FPI-1434. Jun 14, 2021 221
Editas Medicine presents data supporting initiation of EDIT-301 Phase 1/2 RUBY. Jun 11, 2021 203
Mustang Bio reports updated interim Phase 1/2 data for MB-106. Jun 11, 2021 268
Novan reports 'positive' results from B-SIMPLE4 Phase 3 study of SB206. Jun 11, 2021 173
Adamis Pharmaceuticals provides update on clinical trial progress for Tempol. Clinical report Jun 11, 2021 204
X4 reports efficacy, safety data from Phase 1b mavorixafor study. Jun 11, 2021 240
Pharmaxis progresses clinical trial in bone marrow cancer. Jun 11, 2021 381
Orgenesis says enrollment is underway for a Phase 2 rotator cuff repair study of its Tissue Genesis Icellator. Jun 11, 2021 362
Pharmaxis progresses clinical trial in bone marrow cancer. Jun 11, 2021 381
First volunteer at Sussex hospital receives covid booster jab in world-leading trial; A hospital worker has become the first person at a Sussex trust to receive a covid booster jab as part of a world-first clinical trial. Isabella Cipirska Jun 11, 2021 542
Finish clinical trials first before vaccinating minors DOST. Jun 11, 2021 249
Phase II results of Taiwan's COVID-19 vaccine meet safety, efficacy thresholds. Jun 10, 2021 328
When does Bangavax get cleared for clinical trials? Jun 10, 2021 646
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients. Jun 10, 2021 498
First Clinical Trial Application Authorization Received in the EU for its Phase 2 Study of NT-I7 and Opdivo. Jun 10, 2021 338
Texas Children's Hospital, Baylor College & Biological E. Limited enter Phase III Trials in India for "People's COVId-19 Vaccine" for the underserved nations. Jun 10, 2021 287
Texas Children's Hospital, Baylor College & Biological E. Limited enter Phase III Trials in India for "People's COVId-19 Vaccine" for the underserved nations. Jun 10, 2021 288
MigVax's Subunit Oral COVID-19 Vaccine Preclinical Trial Demonstrates Effectivity as a Booster. Jun 10, 2021 151

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |